Iwicki Mark T

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$199,550.00
Insider Sells Quantity
9
Insider Sells Sum
$371,514.18

Insider Activity of Iwicki Mark T

According to the SEC Form 4 filings, Iwicki Mark T, being in a position of

  1. CHIEF EXECUTIVE OFFICER at Kala Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 27099 shares for $147,613,
    over all time since 2021-06-28, has bought 0 shares, and sold 125237 shares for $371,514.

The largest purchase of all time was on 2018-04-03 and amounted to 307000 shares of Pulmatrix, Inc. for $199,550.

The largest sale of all time was on 2021-10-26 and amounted to 55196 shares of Kala Pharmaceuticals, Inc. for $99,353.

Biography of Iwicki Mark T

No biography is available at this moment.

2024-06-26SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
15,168
0.5561%
$4.75$72,048+29.35%
2024-05-31SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
7,392
0.2379%
$6.09$45,017-11.38%
2024-01-04SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
4,539
0.1618%
$6.73$30,547-2.29%
2023-01-04SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
198
0.0065%
$28.54$5,651-66.29%
2022-10-26SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
561
0.0363%
$6.52$3,658+128.67%
2022-06-27SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
7,975
0.011%
$0.37$2,951-16.76%
2022-01-04SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
19,036
0.0265%
$1.30$24,747-72.68%
2021-10-26SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
55,196
0.0849%
$1.80$99,353-61.94%
2021-06-28SaleKala Pharmaceuticals, Inc.
KALA
CHIEF EXECUTIVE OFFICER
15,172
0.0244%
$5.77$87,542-72.03%
2018-04-03PurchasePulmatrix, Inc.
PULM
director
307,000
0.8762%
$0.65$199,550-22.17%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.